Biologische Therapien und Krebs - the European Oncology Nursing ...

8
Seidman AD, Baselga J, Yao TY, et al. HER-2/neu over-expression and clinical taxane sensitivity:
a multivariate analysis in patients with metastatic breast cancer (MBC). Proc Am Soc Clin Oncol
1996;15:104.
Suhai S. Genomics and proteomics. Dordrecht: Kluwer Academic, 2000.
Vogel C, Cobleigh M, Tripathy D, et al. First-line, non-hormonal, treatment of women with HER2
overexpressing metastatic breast cancer with Herceptin (trastuzumab, humanized anti-HER2 antibody).
Proc Am Soc Clin Oncol 2000;19:71A.
Genetische Prädisposition
American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetics
testing for cancer susceptibilty. J Clin Oncol 1994;14:1730–6.
Bardley ANM. The contribution of molecular genetics to the understanding and management of cancer:
potential future applications and implications for nurses. Eur J Cancer Care 1999;8:97–103.
Biesecker BB. Genetic testing for cancer predisposition. Cancer Nurs 1997;20:285–300.
Calzone KA. Genetic predisposition testing: clinical implications for oncology nurses. Oncol Nurs Forum
1997;24:712–18.
Dimond E, Calzone K, Davis J, Jenkins J. The role of the nurse in cancer genetics. Cancer Nurs
1998;21:57–75.
Eng C, Stratton M, Ponder B, et al. Familial cancer syndromes. Lancet 1994;343:709–13.
Giarelli E, Jacobs LA. Issues related to the use of genetic material and information. Oncol Nurs Forum
2000;27:459–67.
Lea DH, Jenkins JF, Francomano CA. Genetics in clinical practice: New directions for nursing and health
care. Sudbury: Jones and Bartlett, 1998.
Loescher LJ. Genetics in cancer prediction, screening, and counseling: Part II, the nurse’s role in genetic
counselling. Oncol Nurs Forum 1995;22(Suppl.):16–19.
Murphy AE. Dealing with uncertainty of developing cancer. Eur J Cancer Care 1999;8:233–7.
Ponder BAJ. Setting up and running a familial cancer clinic. Br Med J 1994;53:732–45.
8.32